Personalis, Inc. (PSNL) Earnings Call Analysis
NASDAQ · Healthcare · Diagnostics & Research
Earnings Reports
-
Personalis (PSNL) Q1 2026: Test Volume Jumps 26% as Ultra-Sensitive MRD Drives Share Gains
May 08, 2026
-
Personalis (PSNL) Q3 2025: MRD Clinical Test Volume Up 364% as Coverage Decisions Near
November 05, 2025
-
Personalis (PSNL) Q1 2025: MRD Test Volumes Surge 52% as Reimbursement Milestones Near
July 07, 2025